Published in Eur J Neurosci on April 01, 1996
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A (2000) 5.20
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest (2007) 3.61
In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A (1998) 3.53
High plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria. Clin Infect Dis (2014) 2.02
Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A (1998) 1.96
Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol (2010) 1.76
Role of erythropoietin in the brain. Crit Rev Oncol Hematol (2007) 1.50
Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A (2000) 1.47
Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev (2013) 1.47
Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models. J Physiol (2011) 1.46
The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. J Clin Invest (2009) 1.40
Survival and proliferative roles of erythropoietin beyond the erythroid lineage. Expert Rev Mol Med (2008) 1.36
Treatment of Parkinson's disease with trophic factors. Neurotherapeutics (2008) 1.35
Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol (2003) 1.29
Erythropoietin. Cold Spring Harb Perspect Med (2013) 1.28
The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection. Kidney Int (2013) 1.27
Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med (2009) 1.14
Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog Neurobiol (2008) 1.13
Erythropoietin and oxidative stress. Curr Neurovasc Res (2008) 1.07
Recent Departures in the Synthesis of Peptides and Glycopeptides. Tetrahedron (2009) 1.07
Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function. Physiology (Bethesda) (2014) 1.07
The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol (2005) 1.01
Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies. J Physiol (2005) 1.00
Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia. Exp Neurol (2011) 1.00
Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. J Physiol (1999) 0.98
Anaemia in kidney disease: harnessing hypoxia responses for therapy. Nat Rev Nephrol (2015) 0.97
A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol (2002) 0.97
Pyruvate protects the brain against ischemia-reperfusion injury by activating the erythropoietin signaling pathway. Stroke (2012) 0.96
Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system. Int J Biol Sci (2014) 0.96
Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling. J Neurosci (2012) 0.95
General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain. PLoS One (2011) 0.93
Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. J Neuroinflammation (2013) 0.92
Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives. Front Cell Neurosci (2013) 0.91
Erythropoietin action in stress response, tissue maintenance and metabolism. Int J Mol Sci (2014) 0.91
Effect of erythropoietin on Glasgow Coma Scale and Glasgow Outcome Sale in patient with diffuse axonal injury. J Res Med Sci (2012) 0.91
Erythropoietin: still on the neuroprotection road. Ther Adv Neurol Disord (2012) 0.90
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl) (2011) 0.89
The role of erythropoietin as an inhibitor of tissue ischemia. Int J Biol Sci (2008) 0.89
Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection. Pediatr Neurol (2014) 0.88
Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria. Malar J (2012) 0.87
Vascular growth factors in neuropsychiatry. Cell Mol Life Sci (2013) 0.86
Erythropoietin in brain development and beyond. Anat Res Int (2012) 0.86
Erythropoietin neuroprotection with traumatic brain injury. Pathophysiology (2012) 0.85
Erectile preservation following radical prostatectomy. Ther Adv Urol (2011) 0.85
Exogenous erythropoietin administration attenuates intermittent hypoxia-induced cognitive deficits in a murine model of sleep apnea. BMC Neurosci (2012) 0.84
The neurobiology of erythropoietin. Cell Mol Neurobiol (2011) 0.84
MIF: mood improving/inhibiting factor? J Neuroinflammation (2014) 0.83
Spinal vascular endothelial growth factor (VEGF) and erythropoietin (EPO) induced phrenic motor facilitation after repetitive acute intermittent hypoxia. Respir Physiol Neurobiol (2012) 0.82
The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats. Korean J Pediatr (2010) 0.82
The putative RNA helicase HELZ promotes cell proliferation, translation initiation and ribosomal protein S6 phosphorylation. PLoS One (2011) 0.82
Erythropoietin receptor (EpoR) agonism is used to treat a wide range of disease. Mol Med (2013) 0.82
Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis. Ther Adv Neurol Disord (2008) 0.82
Trophic factors and stem cells for promoting recovery in stroke. J Vasc Interv Neurol (2010) 0.81
Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmacology (2013) 0.81
Erythropoietin improves neurobehavior by reducing dopaminergic neuron loss in a 6‑hydroxydopamine‑induced rat model. Int J Mol Med (2014) 0.81
Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis. Mol Med (2008) 0.79
Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia. Korean J Physiol Pharmacol (2010) 0.79
Promotion of neurite outgrowth and protective effect of erythropoietin on the retinal neurons of rats. Graefes Arch Clin Exp Ophthalmol (2007) 0.78
Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production. Br J Pharmacol (2013) 0.78
Experimental studies of erythropoietin protection following traumatic brain injury in rats. Exp Ther Med (2012) 0.78
Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus. Mol Psychiatry (2016) 0.78
Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain. J Histochem Cytochem (2011) 0.78
In vitro neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese hamster ovary cells. Cytotechnology (1999) 0.76
Prolyl-4-hydroxylase 2 and 3 coregulate murine erythropoietin in brain pericytes. Blood (2016) 0.75
Erythropoietin negatively regulates pituitary ACTH secretion. Brain Res (2015) 0.75
Erythropoietin for the treatment of subarachnoid hemorrhage: A feasible ingredient for a successful medical recipe. Mol Med (2015) 0.75
Cerebral arteriovenous malformation presenting with polycythemia vera: A case report and literature review. Int J Surg Case Rep (2013) 0.75
Dose effect evaluation and therapeutic window of the neuro-EPO nasal application for the treatment of the focal ischemia model in the Mongolian gerbil. ScientificWorldJournal (2012) 0.75
In vitro neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese hamster ovary cells. Cytotechnology (1999) 0.75
Comparative Response of Brain to Chronic Hypoxia and Hyperoxia. Int J Mol Sci (2017) 0.75
Salidroside Inhibits Inflammation Through PI3K/Akt/HIF Signaling After Focal Cerebral Ischemia in Rats. Inflammation (2017) 0.75
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev (1998) 12.48
Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell (2000) 8.13
Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res (2000) 6.14
Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet (1999) 5.91
Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol (1996) 5.52
Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell (2001) 5.01
World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) methods for the detection of anthelmintic resistance in nematodes of veterinary importance. Vet Parasitol (1992) 4.34
Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol (1996) 4.18
Conditional ablation of beta1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. J Cell Biol (2000) 3.38
Desmoplakin is essential in epidermal sheet formation. Nat Cell Biol (2001) 3.31
Left-right asymmetry and kinesin superfamily protein KIF3A: new insights in determination of laterality and mesoderm induction by kif3A-/- mice analysis. J Cell Biol (1999) 3.14
Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem (1997) 2.81
HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J (2001) 2.73
Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol Cell Biol (1996) 2.72
Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3) J Clin Invest (2000) 2.57
Impaired sodium excretion, decreased glomerular filtration rate and elevated blood pressure in endothelin receptor type B deficient rats. J Mol Med (Berl) (2001) 2.55
Negative feedback regulation of wild-type p53 biosynthesis. EMBO J (1995) 2.52
Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J (2001) 2.51
Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Mol Biol (2000) 2.35
Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J Cell Biol (1998) 2.14
A detachable balloon procedure for a traumatic internal carotid-internal jugular fistula: report of a case. Neurosurgery (1990) 2.10
Biochemical and functional comparison of DNA polymerases alpha, delta, and epsilon from calf thymus. J Biol Chem (1991) 2.08
Embryoid bodies: an in vitro model of mouse embryogenesis. Exp Physiol (2000) 2.02
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature (1997) 1.90
Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A (1995) 1.77
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis (2001) 1.71
Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res (1997) 1.71
Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J Biol Chem (1997) 1.67
A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol (1990) 1.64
Rescuing desmoplakin function in extra-embryonic ectoderm reveals the importance of this protein in embryonic heart, neuroepithelium, skin and vasculature. Development (2001) 1.60
Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas. Lab Invest (2000) 1.59
Near-real-time guidance using intraoperative magnetic resonance imaging for radical evacuation of hypertensive hematomas in the basal ganglia. Neurosurgery (2000) 1.57
Integrators of the cytoskeleton that stabilize microtubules. Cell (1999) 1.56
Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest (2001) 1.54
Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol (1999) 1.54
Results on neutrinoless double-β decay of 76Ge from phase I of the GERDA experiment. Phys Rev Lett (2013) 1.54
The paracrine endothelin system: pathophysiology and implications in clinical medicine. Eur J Clin Chem Clin Biochem (1997) 1.53
PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol (1998) 1.52
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci (2000) 1.48
Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A (2000) 1.47
Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J Exp Med (1997) 1.47
Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc Natl Acad Sci U S A (1996) 1.46
Dynamic changes during evacuation of a left temporal abscess in open MRI: technical case report. Neuroradiology (2002) 1.45
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest (1994) 1.45
Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood (1997) 1.44
Age-dependent expression of the erythropoietin gene in rat liver and kidneys. J Clin Invest (1992) 1.43
The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res (1995) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Intracranial dermoid cysts: variations of radiological and clinical features. Acta Neurochir (Wien) (2008) 1.41
Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol (2000) 1.41
Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia. Clin Microbiol Infect (2005) 1.41
Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. J Appl Physiol (1985) (1989) 1.41
APC mutations in sporadic medulloblastomas. Am J Pathol (2000) 1.40
Intraoperative high dose rate brachytherapy in recurrent or metastatic colorectal carcinoma. Ann Surg Oncol (1998) 1.39
Comparison of BIS and AAI as measures of anaesthetic drug effect during desflurane-remifentanil anaesthesia. Acta Anaesthesiol Scand (2004) 1.39
Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost (1998) 1.38
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest (1997) 1.37
Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg (1992) 1.36
Neuronal activity in the vestibular nuclei of the alert monkey during vestibular and optokinetic stimulation. Exp Brain Res (1977) 1.35
Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res (2000) 1.35
Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4. Nat Cell Biol (2000) 1.34
Regulation of the p59fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphatase. Eur J Immunol (1992) 1.32
Antagonistic influence of Co2 and 2,3 diphosphoglycerate on the Bohr effect of human haemoglobin. Life Sci (1969) 1.32
Cerebellar hemorrhage after supratentorial craniotomy--report of three cases. Neurol Med Chir (Tokyo) (1990) 1.31
Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J Cell Sci (1999) 1.31
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. J Biol Chem (1995) 1.29
p14ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol (2001) 1.27
Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase. Mol Cell Biol (1994) 1.26
Experimental gaze palsies in monkeys and their relation to human pathology. Brain (1984) 1.26
Results of microsurgical extra-intracranial arterial bypass in the treatment of cerebral ischemia. Neurosurgery (1978) 1.25
Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc Natl Acad Sci U S A (1986) 1.25
Intraoperative validation of functional magnetic resonance imaging and cortical reorganization patterns in patients with brain tumors involving the primary motor cortex. J Neurosurg (1999) 1.24
Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) (1992) 1.24
Oocysts of Neospora caninum, Hammondia heydorni, Toxoplasma gondii and Hammondia hammondi in faeces collected from dogs in Germany. Int J Parasitol (2005) 1.23
Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 alpha. Biochem Biophys Res Commun (1996) 1.23
Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab (2001) 1.22
Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int (1997) 1.22